[글로벌-이슈 24] “AstraZeneca Vaccine Starts Immediately After Christmas” Green light to Korea with pre-purchase contract

A new coronavirus infection (Corona 19) vaccine jointly developed by British pharmaceutical company AstraZeneca and Oxford University is expected to be approved for emergency use by British health authorities shortly after Christmas.

The AstraZeneca vaccine was pre-ordered by the Korean government, so it is expected that the vaccine will be available in Korea in February.

According to Reuters on the 23rd (local time), John Bell, a professor at Oxford University of the UK’s vaccine development team, appeared on the BBC’s’Radio 4′. It is expected.”

Professor Bell said, “The regulatory authorities have secured a lot of data confirmed in the clinical trials.” “It seems that it will be difficult to get approval for Christmas two days later (because it is a holiday), but I think the approval will drop immediately after Christmas. It’s all for sure.”

“Immediately after Christmas”, which Professor Bell mentioned, is Monday the 28th as early as weekdays.

Assuming an emergency, it could be the 26th, a Saturday other than Christmas Day.

The UK government, which is struggling with the spread of Corona 19, is expected to start vaccinating immediately after approval of the AstraZeneca vaccine.

The Indian government, the world’s largest vaccine producer, is also on the verge of approving the Astrazeca vaccine.

It is expected that vaccinations will begin in many countries once the vaccine is approved for use in the UK and India.

The same goes for Korea. The only vaccine that the Korean government has successfully signed on to purchase is the AstraZeneca vaccine.

It has secured 20 million doses so far.

Through Kovex, a global vaccine joint procurement project led by the World Health Organization (WHO), it has decided to secure 10 million doses, 10 million doses of Pfizer, 10 million doses of Modena, and 4 million doses of Johnson & Johnson and Janssen, but the contract was signed Was not done.

Global Economic Reporter Myung-Hyun Myung-Hyun [email protected]